Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression.

BACKGROUND Pathological similarities between atherosclerosis and glomerulosclerosis suggest that risk factors for the two processes may be similar. Elevated total homocysteine (tHcy) levels and low B vitamin levels are risk factors for atherosclerosis, but have not been evaluated sufficiently as risk factors for the progression of kidney disease. METHODS Frozen samples from the Modification of Diet in Renal Disease Study were assayed for serum tHcy, cysteine, pyridoxal 5-phosphate (PLP), folate, and vitamin B12 levels in 804 participants. These factors were evaluated in both continuous and categorical analyses as risk factors for glomerular filtration rate (GFR) decline by using univariate and multivariable analyses. RESULTS At baseline, mean tHcy levels in study A (GFR, 25 to 55 mL/min/1.73 m2) and study B (GFR, 13 to 24 mL/min/1.73 m2) were 16.9 micromol/L (median, 15.6 micromol/L) and 23.0 micromol/L (median, 20.5 micromol/L), respectively. Mean follow-up was 2.2 years. Mean GFR declines were -4.35 and -3.65 mL/min/y in studies A and B, respectively. There was no significant association between change in GFR with baseline level of tHcy in univariate (-0.26 mL/min/y per 1-SD unit increase in tHcy level; 95% confidence interval [CI], -0.67 to 0.15) or multivariable (-0.18 mL/min/y per 1-SD unit increase in tHcy level; 95% CI, -0.53 to 0.17) analysis in study A or univariate (0.07 mL/min/y per 1-SD unit increase in tHcy level; 95% CI, -0.36 to 0.51) or multivariable (0.24 mL/min/y per 1-SD unit increase in tHcy level; 95% CI, -0.16 to 0.64) analysis in study B. Similarly, higher cysteine levels and lower B vitamin levels were not associated with faster rates of GFR decline in multivariable analysis in either study. CONCLUSION Higher tHcy or cysteine levels and lower folate, PLP, and vitamin B12 levels are not independent risk factors for progression of nondiabetic kidney disease.

[1]  B. Hultberg,et al.  Homocysteine export from erythrocytes and its implication for plasma sampling. , 1992, Clinical chemistry.

[2]  Y. Sako,et al.  Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. , 1987, Journal of chromatography.

[3]  J. Loscalzo,et al.  Homocysteine and atherothrombosis. , 1998, The New England journal of medicine.

[4]  A. Folsom,et al.  Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. , 1998, Circulation.

[5]  P. Ueland,et al.  Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. , 1989, The Journal of laboratory and clinical medicine.

[6]  R. D'Agostino,et al.  Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. , 1999, Archives of internal medicine.

[7]  R. Holman,et al.  Underestimation of the Importance of Homocysteine as a Risk Factor for Cardiovascular Disease in Epidemiological Studies , 2001, Journal of cardiovascular risk.

[8]  J. Witteman,et al.  Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.

[9]  L. Bouter,et al.  Serum Homocysteine Levels Are Associated With the Development of (Micro)albuminuria: The Hoorn Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[10]  E. Podell,et al.  Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. , 1987, Analytical biochemistry.

[11]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[12]  J. Diamond,et al.  Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. , 1991, Kidney international. Supplement.

[13]  A. Moustapha,et al.  Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. , 1998, Circulation.

[14]  H. Mulec,et al.  The Plasma Levels of Homocysteine Are Elevated in Moderate Renal Insufficiency but Do Not Predict the Rate of Progression , 1999, Nephron.

[15]  P. Nilsson-ehle,et al.  The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. , 1996, Scandinavian journal of clinical and laboratory investigation.

[16]  Korzun Wj,et al.  Stability of plasma total homocysteine concentrations in EDTA-whole blood kept on ice. , 2000 .

[17]  Z. Massy,et al.  Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  P. Ueland,et al.  Total homocysteine in plasma or serum: methods and clinical applications. , 1993, Clinical chemistry.

[19]  S. Vollset,et al.  Plasma homocysteine levels and mortality in patients with coronary artery disease. , 1997, The New England journal of medicine.

[20]  R. D'Agostino,et al.  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. , 1995, The New England journal of medicine.

[21]  G. Beck,et al.  Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. , 1997, Kidney international.

[22]  I. Rosenberg,et al.  Nonfasting Plasma Total Homocysteine Level and Mortality in Middle-Aged and Elderly Men and Women in Jerusalem , 1999, Annals of Internal Medicine.

[23]  A. Bostom,et al.  Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. , 1997, Kidney International.

[24]  P. Wilairatana,et al.  Increased circulating levels of transcobalamin II in malarial patients with renal involvement. , 1993, Annals of tropical medicine and parasitology.

[25]  H. Refsum,et al.  Homocysteine in frozen plasma samples. A short cut to establish hyperhomocysteinaemia as a risk factor for arteriosclerosis? , 1993, Scandinavian journal of clinical and laboratory investigation.

[26]  W. Vermaak,et al.  The effect of blood sample aging and food consumption on plasma total homocysteine levels. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[27]  L. Bouter,et al.  Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. , 1998, Kidney international.

[28]  G. Remuzzi,et al.  Pathophysiology of progressive nephropathies. , 1998, The New England journal of medicine.

[29]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. , 1996, Circulation.

[30]  D. Horne,et al.  Lactobacillus casei microbiological assay of folic acid derivatives in 96-well microtiter plates. , 1988, Clinical chemistry.

[31]  L. Snetselaar,et al.  Baseline characteristics in the Modification of Diet in Renal Disease Study. , 1993, Journal of the American Society of Nephrology : JASN.

[32]  I. Rosenberg,et al.  Serum Total Homocysteine Concentrations in the Third National Health and Nutrition Examination Survey (19911994): Population Reference Ranges and Contribution of Vitamin Status to High Serum Concentrations , 1999, Annals of Internal Medicine.

[33]  I. Rosenberg,et al.  Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[34]  M. Landray,et al.  Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? , 2000, Circulation.

[35]  W. Zidek,et al.  Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. , 1995, Journal of the American Society of Nephrology : JASN.

[36]  S. Vollset,et al.  Plasma Total Cysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project , 2001, Circulation.

[37]  P. Wilson,et al.  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. , 1993, JAMA.

[38]  Tom Greene,et al.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.